Prediction of recurrence from metabolites and expression of TOP2A and EZH2 in prostate cancer patients treated with radiotherapy

Author:

Hansen Ailin Falkmo12,Høiem Therese Stork1,Selnæs Kirsten Margrete3,Bofin Anna Mary4,Størkersen Øystein5,Bertilsson Helena16,Wright Alan J.7,Giskeødegård Guro Fanneløb12ORCID,Bathen Tone Frost1ORCID,Rye Morten Beck46,Tessem May‐Britt16ORCID

Affiliation:

1. Department of Circulation and Medical Imaging, Faculty of Medicine and Health Sciences NTNU—Norwegian University of Science and Technology Trondheim Norway

2. K.G. Jebsen Center for Genetic Epidemiology, Department of Public Health and Nursing, Faculty of Medicine and Health Sciences NTNU Trondheim Norway

3. Department of Radiology and Nuclear Medicine, St. Olavs Hospital Trondheim University Hospital Trondheim Norway

4. Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences NTNU Trondheim Norway

5. Department of Pathology, St. Olavs Hospital Trondheim University Hospital Trondheim Norway

6. Department of Surgery, St. Olavs Hospital Trondheim University Hospital Trondheim Norway

7. Cancer Research UK Cambridge Institute University of Cambridge Cambridge UK

Funder

H2020 European Research Council

Publisher

Wiley

Subject

Spectroscopy,Radiology, Nuclear Medicine and imaging,Molecular Medicine

Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3